Treat to target isn’t just for rheumatoid arthritis patients
You wouldn’t put a patient on the bus and expect them to get to their destination without telling ...
What the GRAPPA?
Clinical outcomes for patients with psoriatic arthritis could be improved thanks to GRAPPA. Not the throat-warming Italian drink, but rather the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), which recently updated its recommendations for treating ...Sponsored by AbbVie
psoriatic-arthritis Sponsored by Pfizer Australia
Mostly progress but a little bit of procrastination in PsA
Psoriatic arthritis (PsA) is finally getting the attention it deserves after spending a long time in the shadows of its big brother rheumatoid arthritis. But are we making progress in treating the disease or are we just procrastinating? We speak ...Sponsored by Pfizer Australia
Study suggests role for interleukin-17A in PsA
The results of a Phase III study suggest an important role for interleukin-17A in the pathogenesis of psoriatic arthritis, investigators of an industry sponsored trial say. Published in the NEJM the randomised study of 606 patients with psoriatic arthritis found ...
Ustekinumab linked with serious skin condition
Doctors should be alert for symptoms of erythrodermic psoriasis or exfoliative dermatitis in their patients taking ustekinumab, the TGA advises. To 20 May 2015, the safety body has received one report of erythrodermic psoriasis associated with ustekinumab treatment, and ...
Methotrexate not linked to lung disease
Methotrexate is not associated with an increased risk of lung disease in patients taking it for psoriatic arthritis, psoriasis, or inflammatory bowel disease, according to a meta-analysis. The prevalence of methotrexate related interstitial lung disease remains ...
Half of PsA patients dissatisfied
Almost half of psoriasis and psoriatic arthritis patients in the US say they are dissatisfied with their treatment, a survey of over 5,000 patients finds. Adverse effects and a lack of effectiveness were the main reasons for discontinuing biological ...